Tioconazole and related compounds for control of Herpes simplex virus
Patent 4661493 Issued on April 28, 1987. Estimated Expiration Date: 
March 6, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 6, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesContraceptive compositions and methods employing 1-substituted imidazole derivatives Contraceptive methods employing 1-substituted imidazole derivatives 2-Deoxy glucose as an antiviral agent against herpes simplex Patent #: 4315001 InventorApplicationNo. 06/837658 filed on 03/06/1986US Classes:514/254.07, Chalcogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding514/329, Nitrogen attached directly to the piperidine ring by nonionic bonding514/396, Imidazoles514/397Additional hetero ringExaminersPrimary: Goldberg, Jerome D.Attorney, Agent or FirmInternational ClassesA61K 31/415 (20060101)A61K 31/495 (20060101) AbstractTopical vaginal forms of tioconazole and related antimicrobic compounds, especially miconazole, econazole, clotrimazole, butaconazole and ketoconazole, are useful for the control (chemotherapeutic and chemoprophylactic) of Herpes virus infections. | |
